{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:44:54Z","timestamp":1791924294579,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773996"],"award-info":[{"award-number":["81773996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017242","name":"National Institutes for Food and Drug Control","doi-asserted-by":"publisher","award":["2022C1"],"award-info":[{"award-number":["2022C1"]}],"id":[{"id":"10.13039\/100017242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF0711100"],"award-info":[{"award-number":["2022YFF0711100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yrtph.2026.106056","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:56:15Z","timestamp":1770882975000},"page":"106056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Application of a next generation risk assessment framework, integrated testing strategy defined approaches and read-across for evaluating the skin sensitization potency: Case studies with 5-hydroxymethylfurfural and 5,5\u2032-oxydimethylenebis (2-furfural)"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7999-3307","authenticated-orcid":false,"given":"Ni","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2026.106056_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/toxsci\/kfs071","article-title":"Differential gene expression responses distinguish contact and respiratory sensitizers and nonsensitizing irritants in the local lymph node assay","volume":"126","author":"Adenuga","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106056_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-69157-1","article-title":"Assessment of performance of the profilers provided in the OECD QSAR toolbox for category formation of chemicals","volume":"14","author":"Aljallal","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yrtph.2026.106056_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yrtph.2007.10.008","article-title":"Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients","volume":"52","author":"Api","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.comtox.2017.10.001","article-title":"Ab initio chemical safety assessment: a workflow based on exposure considerations and non-animal methods","volume":"4","author":"Berggren","year":"2017","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106056_bib5","series-title":"Opinion on Skin Sensitisation Quantitative Risk Assessment for Fragrance Ingredients (QRA2) - Submission I SCCS\/1589\/17 -Final Opinion","author":"Bernauer","year":"2019"},{"key":"10.1016\/j.yrtph.2026.106056_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jat.3448","article-title":"A quantitative in silico model for predicting skin sensitization using a nearest neighbours approach within expert\u2010derived structure\u2013activity alert spaces","volume":"37","author":"Canipa","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106056_bib7","first-page":"1","article-title":"An introduction to chemical grouping, categories and read-across to predict toxicity","author":"Cronin","year":"2013","journal-title":"Chem. Toxicity Predict."},{"key":"10.1016\/j.yrtph.2026.106056_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/10629369408029901","article-title":"Multivariate QSAR analysis of a skin sensitization database","volume":"2","author":"Cronin","year":"1994","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.yrtph.2026.106056_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yrtph.2018.03.003","article-title":"International regulatory requirements for skin sensitization testing","volume":"95","author":"Daniel","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib12","series-title":"ECHA Registered Substances Database","article-title":"Registration dossier for 3-ethoxy-4-hydroxybenzaldehyde","year":"2003"},{"key":"10.1016\/j.yrtph.2026.106056_bib14","series-title":"ECHA Registered Substances Database","article-title":"Registration dossier for 5-(methoxymethyl)-2-furaldehyde","year":"2011"},{"key":"10.1016\/j.yrtph.2026.106056_bib15","series-title":"ECHA Registered Substances Database","article-title":"Registration dossier for 2-bromo-5-hydroxybenzaldehyde","year":"2012"},{"key":"10.1016\/j.yrtph.2026.106056_bib18","series-title":"Toxtree. Version 3.1.0","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106056_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/kfh213","article-title":"Development of a peptide reactivity assay for screening contact allergens","volume":"81","author":"Gerberick","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106056_bib20","first-page":"439","article-title":"Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information","volume":"40","author":"Gilmour","year":"2023","journal-title":"Altex-Alternativ. Animal Experiment."},{"key":"10.1016\/j.yrtph.2026.106056_bib21","first-page":"33","article-title":"Evaluation of the global performance of eight in silico skin sensitization models using human data","volume":"38","author":"Golden","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2026.106056_bib22","first-page":"54","article-title":"Cutaneous safety of fragrance material as measured by the maximization test","volume":"82","author":"Greif","year":"1967","journal-title":"Am. Perfumer Cosmet."},{"key":"10.1016\/j.yrtph.2026.106056_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114008","article-title":"HMF causes anaphylactic symptoms by acting as a H1 receptor agonist","volume":"177","author":"He","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib25","series-title":"An Alternative Test Method Using Fewer Animals to Assess the Allergic Contact Dermatitis Potential of Chemicals and Products","article-title":"Test method evaluation report the reduced murine local lymph node assay","year":"2009"},{"key":"10.1016\/j.yrtph.2026.106056_bib26","article-title":"Simulation of process control for production of 5-HMF from old coconut water","volume":"1192","author":"Joharee","year":"2021","journal-title":"IOP Conf. Ser. Mater. Sci. Eng."},{"key":"10.1016\/j.yrtph.2026.106056_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2009.06.449","article-title":"Quantitative risk assessments for dermal sensitization to fragrance ingredients: the utility of LLNA data in the weight of evidence approach to identifying thresholds","volume":"189","author":"Lalko","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2026.106056_bib28","series-title":"Derek Nexus v6.1.1. Vol. 2024","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106056_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.yrtph.2016.10.008","article-title":"Comparison of in vivo immunomodulatory effects of 5-hydroxymethylfurfural and 5, 5\u2032-oxydimethylenebis (2-furfural)","volume":"81","author":"Lin","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1504\/IJRAM.2017.082566","article-title":"Implementing toxicity testing in the 21st century: challenges and opportunities","volume":"20","author":"Locke","year":"2017","journal-title":"Int. J. Risk Assess. Manag."},{"key":"10.1016\/j.yrtph.2026.106056_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115470","article-title":"Identification and characterization of forced degradation products of 5-hydroxymethyl-2-furaldehyde (5-HMF) by HPLC, LC-LTQ\/Orbitrap and NMR studies","volume":"233","author":"Lu","year":"2023","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.yrtph.2026.106056_bib32","first-page":"473","article-title":"From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment","volume":"30","author":"MacKay","year":"2013","journal-title":"ALTEX-Alternativ. Animal Experiment."},{"key":"10.1016\/j.yrtph.2026.106056_bib33","first-page":"1","article-title":"Production of fermented tea petal decoction with insights into in vitro biochemical tests, antioxidant assay and GC-MS analysis","volume":"3","author":"Majumder","year":"2021","journal-title":"Food Product. Process. Nutr."},{"key":"10.1016\/j.yrtph.2026.106056_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/toxsci\/kfu229","article-title":"Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment","volume":"143","author":"Natsch","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106056_bib35","series-title":"Compound Summary: 2-Bromo-5-Hydroxybenzaldehyde (CID 387179)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib36","series-title":"Compound Summary: 3-Chloro-4-Methoxybenzaldehyde (CID 78619)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib37","series-title":"Compound Summary: 3-Ethoxy-4-Hydroxybenzaldehyde (Ethylvanillin) (CID 8467)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib38","series-title":"Compound Summary: 3,4-Dimethoxybenzaldehyde (Veratraldehyde) (CID 8419)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib39","series-title":"Compound Summary: 4-[2-Chloroethyl(Ethyl)Amino] Benzaldehyde (CID 75842)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib40","series-title":"Compound Summary: 4-Hydroxy-3-Methoxybenzaldehyde (Vanillin) (CID 1183)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib41","series-title":"Compound Summary: 4-Nitrobenzaldehyde (CID 541)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib42","series-title":"Compound Summary: 5-Hydroxymethylfurfural (CID 237332)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib43","series-title":"Compound Summary: 5-Methoxymethylfurfural (CID 74711)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib44","series-title":"Compound Summary: 5-Sulfooxymethylfurfural (CID 154718)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib45","series-title":"Compound Summary: 5,5'-Oxybis(5-Methylene-2-Furaldehyde) (CID 12366272)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib46","series-title":"Compound Summary: Phthalaldehyde (CID 8438)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib47","series-title":"Compound Summary: Piperonal (CID 8438)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106056_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10408444.2022.2033162","article-title":"Implementation of a dermal sensitization threshold (DST) concept for risk assessment: structure-based DST and in vitro data-based DST","volume":"52","author":"Nishijo","year":"2022","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106056_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104732","article-title":"Application of the dermal sensitization threshold concept to chemicals classified as high potency category for skin sensitization assessment of ingredients for consumer products","volume":"117","author":"Nishijo","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2131\/jts.44.23","article-title":"The dermal sensitization threshold (DST) approach for mixtures evaluated as negative in in vitro test methods; mixture DST","volume":"44","author":"Nishijo","year":"2019","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106056_bib51","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.tiv.2012.07.001","article-title":"Prediction of skin sensitization potency of chemicals by human cell line activation test (h-CLAT) and an attempt at classifying skin sensitization potency","volume":"26","author":"Nukada","year":"2012","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2026.106056_bib52","article-title":"Guidance document on the reporting of defined approaches and integrated approaches to testing and assessment (IATA) for skin sensitisation","volume":"256","year":"2016","journal-title":"OECD Series Test. Assessment"},{"key":"10.1016\/j.yrtph.2026.106056_bib53","series-title":"Test Guideline No. 497: Defined Approaches on Skin Sensitisation","year":"2021"},{"key":"10.1016\/j.yrtph.2026.106056_bib54","series-title":"Test Guideline No. 442C: in Chemico Skin Sensitisation_DPRA","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106056_bib55","series-title":"Test Guideline No. 442E in Vitro Skin Sensitisation_h-CLAT","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106056_bib56","series-title":"The OECD QSAR Toolbox (Version 4.7) User Guidance Document","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106056_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tox.2017.10.015","article-title":"Applicability of an integrated testing strategy consisting of in silico, in chemico and in vitro assays for evaluating the skin sensitization potencies of isocyanates","volume":"393","author":"Ohtake","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2026.106056_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2013.06.002","article-title":"Use of category approaches, read-across and (Q) SAR: general considerations","volume":"67","author":"Patlewicz","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yrtph.2007.03.003","article-title":"TIMES-SS\u2014a promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q) SARs and an external evaluation for predictivity","volume":"48","author":"Patlewicz","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib60","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acs.chemrestox.5b00388","article-title":"Current and future perspectives on the development, evaluation, and application of in silico approaches for predicting toxicity","volume":"29","author":"Patlewicz","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106056_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/10629360802083871","article-title":"An evaluation of the implementation of the cramer classification scheme in the toxtree software","volume":"19","author":"Patlewicz","year":"2008","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.yrtph.2026.106056_bib62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/qsar.200390012","article-title":"QSARs for the skin sensitization potential of aldehydes and related compounds","volume":"22","author":"Patlewicz","year":"2003","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.yrtph.2026.106056_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.0105-1873.2004.00322.x","article-title":"Further evaluation of quantitative structure\u2013activity relationship models for the prediction of the skin sensitization potency of selected fragrance allergens","volume":"50","author":"Patlewicz","year":"2004","journal-title":"Contact Dermat."},{"key":"10.1016\/j.yrtph.2026.106056_bib64","series-title":"Essentials of Pharmatoxicology in Drug Research","first-page":"343","article-title":"Thermal processing and food-related toxicants","author":"Pawar","year":"2023"},{"key":"10.1016\/j.yrtph.2026.106056_bib65","series-title":"Silico Methods for Predicting Drug Toxicity","first-page":"435","article-title":"Use of lhasa limited products for the in silico prediction of drug toxicity","author":"Ponting","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106056_bib66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yrtph.2018.04.022","article-title":"Chemical applicability domain of the local lymph node assay (LLNA) for skin sensitisation potency. Part 4. Quantitative correlation of LLNA potency with human potency","volume":"96","author":"Roberts","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/tx060121y","article-title":"Electrophilic chemistry related to skin sensitization. Reaction mechanistic applicability domain classification for a published data set of 106 chemicals tested in the mouse local lymph node assay","volume":"20","author":"Roberts","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106056_bib68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.indcrop.2014.10.014","article-title":"Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach","volume":"63","author":"Rodrigues","year":"2015","journal-title":"Ind. Crop. Prod."},{"key":"10.1016\/j.yrtph.2026.106056_bib69","series-title":"The History of Alternative Test Methods in Toxicology","first-page":"157","article-title":"Animal-free cosmetics in Europe","author":"Rogiers","year":"2019"},{"key":"10.1016\/j.yrtph.2026.106056_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yrtph.2008.02.010","article-title":"The dermal sensitisation Threshold\u2014A TTC approach for allergic contact dermatitis","volume":"51","author":"Safford","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib71","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.yrtph.2015.04.020","article-title":"Extension of the dermal sensitisation threshold (DST) approach to incorporate chemicals classified as reactive","volume":"72","author":"Safford","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106056_bib72","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.tiv.2005.10.014","article-title":"Development of an in vitro skin sensitization test using human cell lines; human cell line activation test (h-CLAT) II. An inter-laboratory study of the h-CLAT","volume":"20","author":"Sakaguchi","year":"2006","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2026.106056_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bcpt.12955","article-title":"Integrated approaches to testing and assessment: OECD activities on the development and use of adverse outcome pathways and case studies","volume":"123","author":"Sakuratani","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106056_bib74","series-title":"The SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation-12th Revision-SCCS\/1647\/22","year":"2023"},{"key":"10.1016\/j.yrtph.2026.106056_bib75","series-title":"Globally Harmonized System of Classification and Labelling of Chemicals (GHS)","author":"Secretariat","year":"2023"},{"key":"10.1016\/j.yrtph.2026.106056_bib24","first-page":"1","article-title":"Perspectives on the current state of evaluation of skin sensitization","author":"Suto","year":"2019","journal-title":"SUMITOMO KAGAKU R&D Rep., 2019, Report 3"},{"key":"10.1016\/j.yrtph.2026.106056_bib76","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/carcin\/15.10.2375","article-title":"5-Sulfooxymethylfurfural as a possible ultimate mutagenic and carcinogenic metabolite of the Maillard reaction product, 5-hydroxymethylfurfural","volume":"15","author":"Surh","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yrtph.2026.106056_bib77","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/acs.chemrestox.6b00055","article-title":"Assessment of Pre- and pro-haptens using nonanimal test methods for skin sensitization","volume":"29","author":"Urbisch","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106056_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2019.100102","article-title":"Using metabolic information for categorization and read-across in the OECD QSAR toolbox","volume":"12","author":"Yordanova","year":"2019","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106056_bib79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.apsb.2017.11.002","article-title":"Rapid and sensitive liquid chromatography\u2013tandem mass spectrometric method for the quantitative determination of potentially harmful substance 5, 5\u2032-oxydimethylenebis (2-furfural) in traditional Chinese medicine injections","volume":"8","author":"Zang","year":"2018","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:15:05Z","timestamp":1775906105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":74,"alternative-id":["S0273230026000292"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106056","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of a next generation risk assessment framework, integrated testing strategy defined approaches and read-across for evaluating the skin sensitization potency: Case studies with 5-hydroxymethylfurfural and 5,5\u2032-oxydimethylenebis (2-furfural)","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106056"}}